LUNAI BIOWORKS INC (RENB) Stock Overview
USA - NASDAQ:RENB - US29350E1047 - Common Stock
RENB Key Statistics, Chart & Performance
The current stock price of RENB is 1.42 USD. In the past month the price decreased by -37.58%. In the past year, price decreased by -70.98%.
RENB Latest News, Press Relases and Analysis
RENB Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.85 | 408.76B | ||
| AMGN | AMGEN INC | 13.81 | 162.12B | ||
| GILD | GILEAD SCIENCES INC | 16.03 | 153.96B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.16 | 109.29B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 62.13B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.69 | 61.40B | ||
| ARGX | ARGENX SE - ADR | 90.64 | 51.39B | ||
| INSM | INSMED INC | N/A | 34.94B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.1 | 34.68B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.70B | ||
| NTRA | NATERA INC | N/A | 25.65B | ||
| BIIB | BIOGEN INC | 9.13 | 21.44B |
Related stock screener links
About RENB
Company Profile
Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. The company is headquartered in Los Angeles, California and currently employs 25 full-time employees. The company went IPO on 2014-11-18. The firm is engaged in harnessing advanced computational biology and AI/machine learning to accelerate drug discovery, diagnostics and strengthen biosecurity capabilities. From high-resolution phenotyping to predictive disease modeling, the Company is pioneering a new era of precision diagnostics-where early detection, patient stratification, and therapeutic targeting converge into a single, adaptive platform. These are designed to transform clinical decision-making, reduce time-to-treatment, and unlock previously inaccessible insights from biological data. Its proprietary platforms in translational analytics, in vivo modeling, and machine vision-accelerating biomarker discovery and therapeutic development in precision neurology and infectious disease.
Company Info
LUNAI BIOWORKS INC
2080 Century Park East, Suite 906
Los Angeles CALIFORNIA US
Employees: 25
Phone: 14539179840
LUNAI BIOWORKS INC / RENB FAQ
What is the stock price of LUNAI BIOWORKS INC today?
The current stock price of RENB is 1.42 USD. The price increased by 12.16% in the last trading session.
What is the ticker symbol for LUNAI BIOWORKS INC stock?
The exchange symbol of LUNAI BIOWORKS INC is RENB and it is listed on the Nasdaq exchange.
On which exchange is RENB stock listed?
RENB stock is listed on the Nasdaq exchange.
What is LUNAI BIOWORKS INC worth?
LUNAI BIOWORKS INC (RENB) has a market capitalization of 327.92M USD. This makes RENB a Small Cap stock.
How many employees does LUNAI BIOWORKS INC have?
LUNAI BIOWORKS INC (RENB) currently has 25 employees.
What are the support and resistance levels for LUNAI BIOWORKS INC (RENB) stock?
LUNAI BIOWORKS INC (RENB) has a resistance level at 1.82. Check the full technical report for a detailed analysis of RENB support and resistance levels.
Should I buy LUNAI BIOWORKS INC (RENB) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RENB, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RENB, evaluating the profitability, health, valuation and growth aspects
- LUNAI BIOWORKS INC (RENB) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- LUNAI BIOWORKS INC (RENB) Sales and EPS estimates to see what analysts future expectations are.
- LUNAI BIOWORKS INC (RENB) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- LUNAI BIOWORKS INC (RENB) Insider and Institutional Ownership to learn about the owners and their transactions.
- LUNAI BIOWORKS INC (RENB) Stock Chart to make your own analysis
- LUNAI BIOWORKS INC (RENB) Latest news and press-releases to stay up to date.
Does LUNAI BIOWORKS INC (RENB) stock pay dividends?
RENB does not pay a dividend.
When does LUNAI BIOWORKS INC (RENB) report earnings?
LUNAI BIOWORKS INC (RENB) will report earnings on 2025-11-12.
What is the Price/Earnings (PE) ratio of LUNAI BIOWORKS INC (RENB)?
LUNAI BIOWORKS INC (RENB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.44).
RENB Technical Analysis
RENB Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to RENB. The financial health of RENB is average, but there are quite some concerns on its profitability.
RENB Financial Highlights
Over the last trailing twelve months RENB reported a non-GAAP Earnings per Share(EPS) of -0.44. The EPS increased by 59.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -57.15% | ||
| ROE | -76.11% | ||
| Debt/Equity | 0 |